Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.2M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
70.1K
-
Shares change
-
-1.07K
-
Total reported value, excl. options
-
$102K
-
Value change
-
-$2.28K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$1.47
Significant Holders of Alaunos Therapeutics, Inc. - Common Stock (TCRT) as of Q1 2025
28 filings reported holding TCRT - Alaunos Therapeutics, Inc. - Common Stock as of Q1 2025.
Alaunos Therapeutics, Inc. - Common Stock (TCRT) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.1K shares
of 2.2M outstanding shares and own 3.18% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (21.4K shares), VANGUARD GROUP INC (21K shares), GEODE CAPITAL MANAGEMENT, LLC (15.6K shares), UBS Group AG (7.87K shares), Tower Research Capital LLC (TRC) (1.68K shares), MORGAN STANLEY (897 shares), OSAIC HOLDINGS, INC. (720 shares), GROUP ONE TRADING LLC (300 shares), WELLS FARGO & COMPANY/MN (216 shares), and Steward Partners Investment Advisory, LLC (98 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.